Previous Article | Next Article ![]()
Journal of Bacteriology, September 1998, p. 4392-4400, Vol. 180, No. 17
Instituto de Investigaciones
Biotecnológicas,
Received 25 February 1998/Accepted 25 June 1998
The animal pathogen Brucella abortus contains a gene,
cgs, that complemented a Rhizobium meliloti
nodule development (ndvB) mutant and an Agrobacterium
tumefaciens chromosomal virulence (chvB) mutant. The
complemented strains recovered the synthesis of cyclic Symbiotic nitrogen-fixing
Rhizobium meliloti and crown gall tumor-inducing
Agrobacterium tumefaciens have in common the ability to
synthesize periplasmic cyclic Brucella spp. are nonmotile gram-negative bacteria that
cause a chronic disease in humans and other animals that results from the survival of the pathogens inside macrophages (34).
Brucella spp., which belong, according to 16S rRNA
sequences, to the same ( (Part of this research was presented at the 96th General Meeting of the
American Society for Microbiology, New Orleans, La., 19 to 23 May
1996.)
Bacterial strains and plasmids.
R. meliloti,
Escherichia coli, A. tumefaciens, and B. abortus strains and plasmids used are listed in Table
1. R. meliloti, E. coli, and A. tumefaciens strains were grown on yeast
extract-mannitol medium (AMA) (22), in Luria broth (LB)
(31), and on tryptone-yeast medium (45),
respectively. B. abortus strains were grown in brucella
broth (BB) (Difco Laboratories, Detroit, Mich.).
DNA techniques, genetic complementation, and
Tn3-HoHo1 mutagenesis.
A B. abortus S19
genomic library was prepared basically as previously described
(37). Total genomic DNA was prepared as described previously
(18) and partially digested with HindIII. Partially digested DNA was ligated to the
HindIII- digested pVK102 vector (23) and
packaged in vitro with a commercial in vitro packaging system according
to the manufacturer's specifications (Amersham, Arlington Heights,
Ill.). Exponential-phase E. coli LE392 cells grown in LB
containing 0.2% maltose and 10 mM MgSO4 were infected with
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Cloning and Characterization of cgs, the
Brucella abortus Cyclic
(1-2) Glucan Synthetase Gene:
Genetic Complementation of Rhizobium meliloti ndvB and
Agrobacterium tumefaciens chvB Mutants
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
(1-2) glucan,
motility, virulence in A. tumefaciens, and nitrogen
fixation in R. meliloti; all traits were strictly associated with the presence of an active cyclic
(1-2) glucan synthetase protein in the membranes. Nucleotide sequencing revealed the
presence in B. abortus of an 8.49-kb open reading frame
coding for a predicted membrane protein of 2,831 amino acids (316.2 kDa) and with 51% identity to R. meliloti NdvB. Four
regions of the B. abortus protein spanning amino acids 520 to 800, 1025 to 1124, 1284 to 1526, and 2400 to 2660 displayed
similarities of higher than 80% with R. meliloti NdvB.
Tn3-HoHo1 mutagenesis showed that the C-terminal 825 amino
acids of the Brucella protein, although highly conserved in
Rhizobium, are not necessary for cyclic
(1-2) glucan
synthesis. Confirmation of the identity of this protein as B. abortus cyclic
(1-2) glucan synthetase was done by the construction of a B. abortus Tn3-HoHo1
insertion mutant that does not form cyclic
(1-2) glucan and lacks
the 316.2-kDa membrane protein. The recovery of this mutant from the
spleens of inoculated mice was decreased by 3 orders of magnitude
compared with that of the parental strain; this result suggests that
cyclic
(1-2) glucan may be a virulence factor in
Brucella infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
(1-2) glucan (2, 17, 26, 41,
42). This glucan is required, through a still-unknown mechanism,
for effective nodule invasion or crown gall tumor induction (12,
14, 28). chvB in A. tumefaciens and
ndvB in R. meliloti were identified as the genes
coding for a high-molecular-weight inner membrane protein characterized
as cyclic
(1-2) glucan synthetase (45). The
ndvB and chvB genes are interchangeable, and
mutations in one gene can be complemented by the other, indicating that their functions are highly conserved (12). Cyclic
(1-2)
glucan synthetase contains all the enzymatic activities required for the synthesis of cyclic glucan, i.e., initiation, elongation, and
cyclization (1, 4). The protein acts as an intermediate; it
has been postulated that a linear polyglucose chain covalently bound
through the reducing end to an as-yet-unidentified amino acid elongates
until it reaches the appropriate degree of polymerization and
thereafter is cyclized and released from the protein. All of these
reactions are believed to take place on the cytoplasmic side of the
inner membrane; it has been postulated that an inner membrane protein
encoded by chvA in A. tumefaciens is responsible for secretion of the nonsubstituted cyclic glucan into the
periplasm, where glycerol phosphate, succinate, and methyl malonate
are added (21). Besides being defective in cyclic glucan
synthesis, chvB and ndvB mutants are also
defective in the assembly of flagella, having a nonmotile phenotype as
a consequence (10, 14).
2) group of the
Proteobactereaceae (7) as R. meliloti
and A. tumefaciens, are also able to synthesize cyclic
(1-2) glucan (3). We recently studied the biosynthesis of cyclic
(1-2) glucan in Brucella abortus and B. ovis. A high-molecular-weight inner membrane protein similar to
that observed in R. meliloti and A. tumefaciens
was identified as cyclic
(1-2) glucan synthetase (3). Two
differences were observed between the Brucella and Agrobacterium or Rhizobium cyclic
(1-2) glucan
synthetases: (i) isolated Brucella membranes are defective
in the cyclization reaction in vitro, accumulating a
high-molecular-weight linear glucan on the protein intermediate after a
chase with 2 mM UDP-glucose, and (ii) the accumulation of glucan in
Brucella is not osmoregulated (3). The role of
this glucan in Brucella-host interactions is not known yet.
In the present work, we applied a functional complementation approach
to clone a Brucella gene equivalent to chvB and
ndvB from a B. abortus S19 gene library, based on
the ability of recombinant cosmids to restore the motility of an
R. meliloti ndvB mutant. We identified and characterized
recombinant plasmids able to restore all the functions assigned to the
ndvB locus of R. meliloti and the chvB
locus of A. tumefaciens, i.e., the presence of a
high-molecular-weight inner membrane protein, the synthesis of cyclic
(1-2) glucan, motility, and the ability to form normal
nitrogen-fixing nodules in alfalfa roots and crown gall tumors in
Kalanchoe daigremontiana leaves. The complete nucleotide sequence of the B. abortus S19 gene equivalent to
ndvB and chvB is given.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Bacteria and plasmids
phage particles at 30°C for 30 min, followed by the addition of 1 volume of LB. After 2 h of incubation at 37°C, cells were plated
on LB agar containing 20 µg of tetracycline per ml.
Tetracycline-resistant clones that were kanamycin sensitive (100 µg/ml) were candidates to harbor plasmids with inserted B. abortus DNA fragments. Twelve pools containing 100 individual clones from the B. abortus S19 gene bank (representing
approximately five times the genome) were mass conjugated by
triparental mating (9) into an R. meliloti GRT21s
ndvB mutant (38).
-D-galactopyranoside.
Mapping of insertions affecting motility (motile and nonmotile) in
pBA19 was carried out by digesting cosmids recovered from E. coli HB101 strains with HindIII and
EcoRI restriction enzymes. Gel electrophoresis on 0.8%
agarose was used to estimate the sizes of the generated fragments.
Precise mapping of Tn3-HoHo1 insertions I129, I121, M47, and
M14 was carried out by DNA sequencing with an oligonucleotide
(5'TAAAAGAGGCGTCAGAGG3') complementary to a region located
50 bp downstream of the end of the left inverted repeated of the
transposon. For nucleotide sequencing, the DNA cloned in pBA19 was
subcloned in pBCSK(+) (Stratagene, La Jolla, Calif.). DNA sequencing
was carried out by the dideoxy method (33) with an automated
model 373 DNA sequencer (Perkin-Elmer Applied Biosystems Division,
Foster City, Calif.) according to the manufacturer's instructions.
Protein alignment and comparisons were carried out by the Clustal
method (15). Prediction of transmembrane helix regions and
topology was carried out as described previously (30).
Isolation of
(1-2) glucan from cells.
Cells from 100-ml
cultures were harvested by centrifugation at 10,000 × g for 10 min. Pellets were extracted with 1%
trichloroacetic acid (TCA), and the extracts were subjected to gel
filtration on a Bio-Gel P4 column (78 by 1.8 cm) (Bio-Rad Laboratories,
Richmond, Calif.) as previously described (8, 21).
Alternatively, cells from 3-ml cultures were washed once with 1 ml of
water and centrifuged in an Eppendorf centrifuge, and glucans were
extracted from the pellets with 0.3 ml of 70% ethanol at 37°C over
1 h. The cells were centrifuged in an Eppendorf centrifuge, and
the supernatants were dried in a Speed-Vac centrifuge. Extracted
glucans were redissolved in 70% ethanol and subjected to thin-layer
chromatography (TLC) on Silica Gel-60 plates (Merck KGaA, Darmstadt,
Germany) developed with n-butanol-ethanol-water (5:5:4,
vol/vol) as described previously (43). Glucans on the TLC
plates were detected by spraying with 5% sulfuric acid in ethanol and
heating for 5 min at 120°C.
Acid hydrolysis, paper chromatography, reduction with sodium borohydride, and paper electrophoresis. Acid hydrolysis, paper chromatography, reduction with sodium borohydride, and paper electrophoresis were carried out as described previously (21, 22).
In vitro synthesis of cyclic
(1-2) glucans.
In vitro
synthesis of cyclic
(1-2) glucans was carried out, depending on the
experiment, with three different type of enzyme preparations:
permeabilized cells, total membranes, or inner membranes. Inner and
total membranes were prepared by a modification of the Osborn-Munson
method (27) as previously described (45). The membranes were resuspended in 30 mM HCl-Tris buffer (pH 8.0)-3 mM EDTA
at approximately 40 mg of protein per ml and stored at
20°C until
used. For the preparation of permeabilized cells, cultures were
harvested by centrifugation (10,000 × g for 20 min), and cell pellets were resuspended in 0.01 M EDTA-Tris buffer (pH 8.2)
and subjected to four cycles of freezing and thawing in liquid nitrogen. Total membranes, inner membranes, or permeabilized cells were
incubated with UDP-[14C]glucose (300,000 cpm; 300 µCi/µmol) in 50 mM HCl-Tris buffer (pH 8.2)-10 mM
MgCl2 as previously described (3).
Polyacrylamide gel electrophoresis (PAGE) of membrane proteins and
fluorography were carried out as described previously (45).
Nodulation and virulence test. Alfalfa seeds were surface sterilized with concentrated sulfuric acid for 30 s and washed several times with sterile distilled water until total removal of the acid. Seeds were germinated on wet filter paper in petri dishes. Two-day-old seedlings were planted in autoclaved modified Leonard jars filled with vermiculite and Jensen's N-free solution (39). Seedlings were dipped into a 2-day-old Rhizobium culture immediately before planting. After 4 weeks, plants were removed, nitrogen fixation was evaluated by the acetylene reduction assay as described previously (40), and Rhizobium strains were isolated from nodules as described previously (20). Virulence assays were carried out on Kalanchoe leaves as previously described (13).
Construction of a B. abortus
(1-2) glucan
synthetase mutant.
Mutagenesis was carried out by gene replacement
of the B. abortus cyclic
(1-2) glucan synthetase
wild-type gene with a Tn3-HoHo1-mutated gene. Plasmid pI129
(Tcr Ampr) with a Tn3-HoHo1
insertion in the ClaI-EcoRI 1.5-kb DNA fragment (Fig. 1) was conjugated into B. abortus S19. The transconjugant strain, B. abortus(pI129), was selected on BB agar with nalidixic acid (5 µg/ml), carbenicillin (100 µg/ml), and tetracycline (2 µg/ml).
Homogenotization of the mutated gene into the B. abortus chromosome was carried out by conjugation into B. abortus(pI129) of the incompatible plasmid pPH1JI
(Gmr) as described previously (16).
Single-crossover integration events were selected on BB agar with
gentamicin (4 µg/ml) and carbenicillin (100 µg/ml). Double
crossover events were selected by streaking colonies in duplicate on BB
agar with carbenicillin (100 µg/ml), nalidixic acid (5 µg/ml), and
tetracycline (2 µg/ml) and BB agar with carbenicillin (100 µg/ml)
and nalidixic acid (5 µg/ml). Colonies that were carbenicillin and
nalidixic acid resistant and tetracycline sensitive were selected as
possible double recombinants.
|
Experimental infection of mice.
Two groups of five female
9-week-old BALB/c mice were injected intraperitoneally, one with
5.1 × 108 ± 4.2 × 108 CFU of
B. abortus S19 and the other with 3.4 × 108 ± 1.0 × 108 CFU of the
cgs mutant B. abortus BAI129. At 30 days
postinfection, mice were bled from the retrorbital sinus and sera were
stored at
20°C until used. Animals were killed by cervical
dislocation, spleens were weighed and homogenized in 1 ml of 150 mM
NaCl, and homogenates were serially diluted and plated in duplicate on
BB agar. Colonies were counted after 4 days of incubation at 37°C.
KELA. Antibodies against B. abortus lipopolysaccharide (LPS) were measured in an indirect, computer-assisted kinetics-based enzyme-linked assay (KELA) as described previously (6). The rate, expressed as a slope, was proportional to the amount of antibody in the sample and was determined from linear regression analysis of absorbance versus time; slope values (103) were given as titers of antibodies.
Nucleotide sequence accession number.
The sequence of the
B. abortus cyclic
(1-2) glucan synthetase gene
(cgs) has been assigned GenBank accession no. AF047823.
| |
RESULTS |
|---|
|
|
|---|
Identification of a B. abortus genetic determinant that restores the motility of R. meliloti ndvB and A. tumefaciens chvB mutants. Mass conjugation of the B. abortus S19 gene bank into the R. meliloti GRT21s ndvB mutant led to the isolation of recombinant clones with restored motility on soft-agar plates. Representative motile clones were selected and conjugated back into E. coli HB101 by the triparental mating method (9) in order to isolate the corresponding complementing cosmids. Digestion with restriction enzyme HindIII revealed the presence of two different cosmids with overlapping DNA fragments, pBA19 with a 19-kb insert and pBA25 with a 25-kb insert (Fig. 1). Conjugation of cosmids pBA19 and pBA25 into the A. tumefaciens A1011 chvB mutant restored the motility of the mutant, indicating that both cosmids contain the appropriate genetic information to complement the nonmotile phenotype of both A. tumefaciens chvB and R. meliloti ndvB mutants.
B. abortus cosmids pBA19 and pBA25 complement nodule invasion and virulence of R. meliloti ndvB and A. tumefaciens chvB mutants. Cosmids pBA19 and pBA25 restored the formation of normal nodules by the R. meliloti GRT21s ndvB mutant. As shown in Table 2, R. meliloti GRT21s(pBA19) and R. meliloti GRT21s(pBA25) induced the formation of nodules with wild-type levels of nitrogen fixation activity. When both cosmids were introduced by conjugation into the avirulent A. tumefaciens A1011 chvB mutant, the resulting recombinant strains, A. tumefaciens A1011(pBA19) and A. tumefaciens A1011(pBA25), recovered virulence on Kalanchoe leaves (Table 2). These results demonstrated that both pBA19 and pBA25 contain a gene(s) able to complement the functions assigned to the R. meliloti ndvB and A. tumefaciens chvB genes.
|
Mapping and nucleotide sequencing of the ndvB- and chvB-complementing function on cosmid pBA19. Cosmid pBA19 was selected for further studies. It was recovered from R. meliloti GRT21s(pBA19) by back conjugation into E. coli HB101 by the triparental mating method and was subjected to restriction enzyme analysis and subcloning. The restriction maps of the DNA insert present in pBA19 as well as some subclones are shown in Fig. 1. Subclones pBBE52 (5.2-kb EcoRI fragment), pBBE45 (4.5-kb EcoRI fragment), pBBE50 (5.0-kb EcoRI fragment), pVKH43 (4.3-kb HindIII fragment), and pBBC10 (10.6-kb ClaI fragment), harboring overlapping DNA fragments, were analyzed to study their ability to restore motility or the nodulation phenotype to the R. meliloti GRT21s ndvB mutant. As indicated in Fig. 1, none of these recombinant plasmids could restore motility or the nodulation phenotype to the R. meliloti GRT21s ndvB mutant. Therefore, none of these plasmids contained the complete gene required for complementation.
To map the region harboring all the information needed for complementation, plasmid pBA19 was subjected to Tn3-HoHo1 mutagenesis as described in Materials and Methods. A collection of Tn3-HoHo1 insertions was generated and analyzed. Figure 1 shows that two classes of Tn3-HoHo1 insertions were obtained: class 1 did not restore motility to the R. meliloti GRT21s mutant, and class 2 retained complementing ability. These results defined a maximum region of 8 kb in the DNA insert in pBA19 that is required for restitution of motility. The nucleotide sequence of this 8-kb region was determined. An open reading frame (ORF) encompassing an 8.49-kb fragment flanked by ClaI and BamHI sites was found (Fig. 1). This ORF encoded a high-molecular-mass protein of 316.2 kDa. In the promoter region at
45 bp from the putative ATG start codon there was a
conserved
10 consensus sequence for a sigma 70 RNA polymerase;
however, no
35 consensus sequence was observed. At
12 bp from the
putative ATG start codon a conserved Shine-Dalgarno sequence was
observed. At 144 bp downstream of a putative TAA stop codon a possible
transcriptional terminator stem-loop of 11 inverted repeat bases
flanked by T-rich regions was present.
Analysis of the amino acid sequence of the cyclic
(1-2) glucan
synthetase.
Analysis of the 2,831-amino-acid-residue cyclic
(1-2) glucan synthetase protein indicated that it has the features
of a membrane protein. Comparison with protein databases showed that
this sequence has an overall identity of 51% with the R. meliloti NdvB protein sequence. Tn3-HoHo1 insertions
that did not restore motility and cyclic
(1-2) glucan synthesis
mapped in the region encoding the N-terminal half of the protein.
However, at the 3' end of the ORF, Tn3-HoHo1 insertions that
had no effect on motility and cyclic glucan synthesis were found (see
insertions M47, M14, M202, M20, M30, and M432 in Fig. 1), suggesting
that the C-terminal region of the protein may be dispensable for cyclic
glucan synthesis.
(1-2) glucan synthetase has six transmembrane regions from
positions 424 to 442, 455 to 472, 818 to 835, 840 to 858, 946 to 962, and 967 to 984. These regions may determine three cytoplasmic domains that share the highest sequence similarity with the NdvB protein.
The C-terminal region of the Brucella and the
Rhizobium proteins shows overall identities of 27 and 28%
with the complete cellobiose and cellodextrin phosphorylases of
Clostridium stercorarium, respectively. It is remarkable
that this region of the protein is highly conserved, although it is not
required for glucan synthesis. It remains to be established if the
(1-2) glucan synthetase has cellobiose and/or cellodextrin
phosphorylase enzymatic activity.
Motility of and synthesis of cyclic
(1-2) glucan by the R. meliloti ndvB mutant complemented with cosmids with different
Tn3-HoHo1 insertions.
Since it was previously found
that R. meliloti GRT21s ndvB and A. tumefaciens A1011 chvB mutants do not form cyclic
(1-2) glucans and display a pleiotropic nonmotile phenotype
(10, 14, 28), we decided to determine if the restoration of
motility correlates with the restitution of cyclic glucan synthesis in the R. meliloti GRT21s mutant harboring cosmids with
insertions affecting motility (nonmotile and motile). Table 2 shows
that the introduction of cosmids pBA19 and pBA25 restored in both
bacteria motility and the synthesis of
(1-2) glucans. In order to
study the correlation between the restoration of both phenotypes,
R. meliloti GRT21s strains harboring cosmids with different
Tn3-HoHo1 insertions (Fig. 1) were subjected to glucan
extraction and characterization by TLC. As shown in Fig.
2, insertions that did not restore
motility were negative for the synthesis of glucans (see insertions
I133, I129, I132, and I121 in Fig. 2), whereas insertions that did not affect motility were positive for the synthesis of glucans (see insertions M47, M14, and M21 in Fig. 2). These results indicate that
both functions mapped to the same DNA region of cosmid pBA19 and that
there was a strict correlation between the restoration of motility and
the restitution of cyclic
(1-2) glucan synthesis.
|
(1-2) glucan synthetase have any role in
regulating the synthesis and the type of glucans formed.
Characterization of cyclic
(1-2) glucans produced by
ndvB mutants complemented with cosmid pBA19.
Membranes
from B. abortus S19, wild-type R. meliloti GR4,
and the R. meliloti GRT21s ndvB mutant
complemented with cosmid pBA19, strain GRT21s(pBA19), were used as
enzyme sources for the synthesis in vitro of cyclic
(1-2) glucans as
described in Materials and Methods. The products were characterized as
cyclic
(1-2) glucans by total and partial acid hydrolysis, reduction
with borohydride, and TLC (data not shown). The apparent degree of
polymerization of glucans formed in vitro was determined by
chromatography on Bio-Gel P4 columns. R. meliloti
GRT21s(pBA19) synthesized in vitro a cyclic
(1-2) glucan with a
degree of polymerization identical to that of the glucan formed by
B. abortus S19 membranes and slightly smaller than that of
the glucan synthesized by wild-type R. meliloti GR4
membranes, indicating that complementation was achieved in a
heterologous background. Experiments carried out with the A. tumefaciens A1011 chvB mutant complemented with plasmid
pBA19 resulted in the formation of a glucan with the same degree of polymerization.
Identification by PAGE of the B. abortus cyclic
(1-2) glucan synthetase.
It was previously found that in the
Rhizobiaceae, cyclic
(1-2) glucan synthetase is an inner
membrane protein with apparent molecular masses of approximately 235 kDa as determined by PAGE (45) and of 319 kDa as determined
by nucleotide sequence analysis (19). The enzyme can be
pulse-labeled with UDP-[14C]glucose and chased with
nonradioactive UDP-glucose, due to the fact that the protein itself is
an intermediate during the synthesis of cyclic
(1-2) glucan
(45). It was also found that in B. abortus, cyclic
(1-2) glucan synthetase has an apparent molecular mass similar to that of the A. tumefaciens enzyme (3).
When Brucella membranes are used as an enzyme source, the
cyclization reaction is defective, and no chase effect is observed upon
the addition of nonlabeled UDP-glucose (3). The property of
being labeled after a pulse incubation with
UDP-[14C]glucose allows the rapid identification of the
protein by PAGE after fluorography.
|
|
(1-2) glucan synthetases. Figure 4, lane 2, shows that in the B. abortus BAI129 cgs mutant, the
high-molecular-weight protein was not present and that no other protein
became labeled upon incubation with UDP-[14C]glucose. The
R. meliloti GRT21s ndvB mutant (Fig. 4A, lane 4) complemented with cosmid pBA19 (lane 5) overproduced a protein with the
same apparent molecular weight as the wild-type B. abortus protein (lane 1). On the other hand, this Rhizobium mutant
complemented with cosmid pM14 (Fig. 1) produced a shorter protein (Fig.
4A, lane 6) that became labeled after incubation with
UDP-[14C]glucose (Fig. 4B, lane 6) and that was active in
the synthesis of cyclic glucan (Fig. 2, lane 10). These results
indicated that there is a region at the C terminus of cyclic
(1-2)
glucan synthetase not required for the synthesis of cyclic glucan.
These results demonstrated that restitution of the wild-type phenotype
of the R. meliloti ndvB mutant was accomplished by the
expression in the Rhizobium background of the B. abortus cyclic
(1-2) glucan synthetase protein.
The same results were obtained when plasmid pBA19 was used to
complement the A. tumefaciens A1011 chvB mutant.
Figure 5A, lanes 1 and 2, shows that
membranes of wild-type A. tumefaciens A348 contained a
high-molecular-weight protein which could be pulse-labeled with
UDP-[14C]glucose and chased with 2 mM nonradioactive
UDP-glucose (Fig. 5B, lanes 1 and 2). A1011 chvB mutant
membranes lacked this protein (Fig. 5A, lanes 3 and 4), and no other
protein became labeled upon incubation with
UDP-[14C]glucose (Fig. 5B, lanes 3 and 4). The
introduction of cosmid pBA19 in mutant strain A1011(pBA19) restored the
presence of a high-molecular-weight membrane protein with an apparent
molecular weight indistinguishable from that of the protein present in
the wild-type A. tumefaciens strain (Fig. 5A, lanes 5 and
6). The protein became labeled upon incubation with
UDP-[14C]glucose; however, no chase was observed after
the addition of 2 mM nonradioactive UDP-glucose (Fig. 5B, lanes 5 and
6). The high-molecular-weight protein was overexpressed in strain
A1011(pBA19) (Fig. 5A, lanes 5 and 6). Membranes of strain
A1011(pBA19) contained, besides the high-molecular-weight protein,
several labeled proteins having lower molecular weights (Fig. 5B, lanes
5 and 6). They probably represented products of proteolytic
degradation. Figure 5B, lanes 7 and 8, shows that, as described for
B. abortus (3), when permeabilized cells were
used as an enzyme source, a normal chase effect was observed after the
addition of nonradioactive UDP-glucose, and no proteolytic degradation
products were observed. We concluded that pBA19 codes for the
functional B. abortus cyclic
(1-2) glucan synthetase gene
(cgs), which is functional in A. tumefaciens and
R. meliloti.
|
Site-directed mutagenesis of the B. abortus cgs
gene.
Further confirmation that the B. abortus cgs gene
is responsible for the synthesis of cyclic
(1-2) glucan was obtained
by constructing a mutant by Tn3-HoHo1 mutagenesis. Cosmid
pBA19 harboring Tn3-HoHo1 insertion I129 (Fig. 1) was
conjugated into wild-type B. abortus S19, and double
recombination events and gene replacements were obtained as described
in Materials and Methods. Tn3-HoHo1 insertion I129 in pBA19
was located, by DNA sequencing as described in Materials and Methods,
3,055 bp downstream of the putative ATG start codon of the
cgs ORF. Mutant BAI129 was obtained, and the formation of
cellular cyclic
(1-2) glucan and the presence of the
high-molecular-weight membrane protein were studied. As shown in Fig.
2, lane 4, mutant BAI129 did not accumulate cellular glucan. PAGE of
B. abortus BAI129 revealed that the high-molecular-weight protein was absent (Fig. 4A, lane 2); moreover, upon incubation with
UDP-[14C]glucose, no labeled protein was detected (Fig.
4B, lane 2). Thus, the gene identified in pBA19 codes for the B. abortus cyclic
(1-2) glucan synthetase. Cosmid pBA19 harboring
Tn3-HoHo1 insertion M47, located, by DNA sequencing as
described in Materials and Methods, 6,019 bp downstream of the putative
ATG start codon of the cgs ORF, restored the synthesis of
cyclic
(1-2) glucan to wild-type levels in the B. abortus
BAI129 cgs mutant (3.38 mg of glucose equivalents g of cell
pellet [wet weight]
1). This result indicated that a
truncated cyclic
(1-2) glucan synthetase protein is active in cyclic
(1-2) glucan synthesis in the Brucella background.
Persistence of the B. abortus S19 cgs
mutant in mice.
In order to assess the possible role of cyclic
(1-2) glucan in the infectivity of B. abortus S19,
experimental infections of mice were carried out as described in
Materials and Methods. One group of BALB/c mice was injected with
B. abortus S19 (5.1 × 108 ± 4.2 × 108 CFU), and the other was injected with the B. abortus BAI129 cgs mutant (3.4 × 108 ± 1.0 × 108 CFU). Titers of antibodies against
B. abortus LPS, weights of spleens, and the persistence of
live bacteria in spleens were estimated 30 days postinfection. From
spleens of mice inoculated with B. abortus S19, 9.6 × 105 ± 2.7 × 105 CFU per spleen was
recovered; on the other hand, from spleens of animals inoculated with
the B. abortus BAI129 cgs mutant, only 1.5 × 103 ± 0.1 × 103 CFU was recovered.
These results indicated that the level of persistence of the
cgs mutant in the inoculated animals was approximately 3 orders of magnitude lower than that of parental strain B. abortus S19. Moreover, the spleen weights were 417 ± 20 mg
with B. abortus S19, 191 ± 16 mg with the
cgs mutant, and 83 ± 6 mg for the control, noninfected
animals. LPS antibody titers, estimated by KELA, were 65 with B. abortus S19 and 37 with the cgs mutant. These results indicated that the cgs mutant induced an immunological
response against LPS that was still good although 56.9% lower than
that elicited by B. abortus S19. These data suggested that
the cgs mutation reduced the virulence of B. abortus S19 in mice.
| |
DISCUSSION |
|---|
|
|
|---|
Two cosmids (pBA19 and pBA25) containing overlapping DNA inserts
that restored the wild-type phenotype of nodulation to the R. meliloti GRT21s ndvB mutant were isolated from a gene
bank of B. abortus S19. The complemented strains recovered
both the synthesis of cyclic
(1-2) glucans and motility. Both traits
were strictly associated with the presence of a high-molecular-weight inner membrane protein, similar to that encoded by the A. tumefaciens chvB and R. meliloti ndvB genes and
identified as the cyclic
(1-2) glucan synthetase (19,
45). The properties of the cyclic
(1-2) glucan synthetase and
the degree of polymerization of the cyclic
(1-2) glucans synthesized
by the transconjugant strains are similar to those of the B. abortus S19 cyclic
(1-2) glucan synthetase described previously
(3). We conclude that plasmids pBA19 and pBA25 contain a
gene (cgs) which encodes the Brucella cyclic
(1-2) glucan synthetase, which is functional in R. meliloti and A. tumefaciens backgrounds, and which is
able to complement ndvB and chvB mutants.
It is interesting that although Brucella is a nonmotile
bacterium, due to a lack of flagella, restoration of the synthesis of
cyclic
(1-2) glucan, nodule invasion, and virulence in R. meliloti and A. tumefaciens were associated with
the recovery of motility. The pleotropic nonmotility effect observed
for ndvB and chvB mutants has been assigned to a
defect in flagellum assembly (10). Random
Tn3-HoHo1 mutagenesis of plasmid pBA19 and screening for
loss of the ability to restore motility in R. meliloti ndvB mutants led to the identification of an 8-kb DNA fragment containing the complementing function. However, the region defined by
Tn3-HoHo1 mutagenesis was smaller than that expected for the
codification of the complete cyclic
(1-2) glucan synthetase membrane
protein, according to sequence data. This apparent paradox was also
observed for A. tumefaciens chvB mutants, where it was
observed that a truncated protein of 150 kDa was active in the
synthesis of cyclic
(1-2) glucan; consequently, the virulence locus
was smaller than the complete protein gene (44). Inner
membranes prepared from R. meliloti GRT21s complemented with
a plasmid containing Tn3-HoHo1 insertion M14 (position 6519 of the cgs gene) led to the synthesis of a shorter protein
that was active in the synthesis of cyclic
(1-2) glucan and had
restored motility. These results demonstrated that in
Brucella, as in Agrobacterium, there is a region
at the carboxy terminus of the protein that is not required for the
synthesis of the cyclic glucan. The function of this highly conserved
region of the protein remains to be determined. It is interesting,
however, that this region shows high similarity to cellobiose and
cellodextrin phosphorylases from C. stercorarium
(29).
Cyclic
(1-2) glucans are involved in osmoregulation and play an
important role in symbiosis and tumorigenesis. The finding that
B. abortus cgs was able to complement R. meliloti
ndvB mutants (defective in nodule invasion) and A. tumefaciens chvB mutants (defective in tumor induction) led to
speculation about the role of cgs in
Brucella-cell interactions. The attenuated strain B. abortus S19 is widely used as a live vaccine, although it
conserves a low degree of virulence (36). B. abortus S19 replicates in the spleens of mice during the first 2 weeks postinfection and persists for 12 weeks (36). Cyclic
(1-2) glucan is produced by B. abortus and other species
of Brucella; however, it does not induce in their hosts the
formation of antibodies (5). To our knowledge, no mutants
affected in the synthesis of cyclic
(1-2) glucan had been obtained
so far for B. abortus or any other species of
Brucella. This is the first report in which such a mutant
was obtained and its virulence in mice was studied. We showed that the
B. abortus BAI129 cgs mutant displayed reduced virulence in mice, according to the criteria of spleen weight and
number of live bacteria recovered from the spleens 4 weeks postinfection. These results suggested that in B. abortus,
as in A. tumefaciens and R. meliloti, the lack of
cyclic
(1-2) glucan affects bacterium-host interactions. Therefore,
it seems likely that cgs in B. abortus is a
virulence gene, like chvB in A. tumefaciens. The
fact that cyclic
(1-2) glucan does not induce the formation of
antibodies may make it a very efficient factor for the survival of
Brucella spp. inside the host. The effect of the
cgs mutation in fully pathogenic strains of B. abortus and other species of Brucella remains to be
studied.
| |
ACKNOWLEDGMENTS |
|---|
Nora Iñón de Iannino and Gabriel Briones contributed equally to this work.
We thank J. J. Cazzulo for critical reading of the manuscript, E. W. Nester for providing A. tumefaciens strains and plasmids for Tn3-HoHo1 mutagenesis, M. E. Kovach for providing the pBBR1 MCS2 plasmid, A. Vigliocco for providing Brucella strains and useful suggestions, Fernando Pieckenstain for helping in acetylene reduction assays, and Susana Raffo and María de los Angeles Curtó (from Consejo Nacional de Investigaciones Científicas y Técnicas de la República Argentina [CONICET]) for preparing UDP-[14C]glucose.
This work was supported in part by a grant from the Ministerio de Cultura y Educación, República Argentina, to the Instituto de Investigaciones Biotecnológicas de la Universidad Nacional de General San Martín. We acknowledge the financial support of the Comisión Nacional de Energía Atómica, República Argentina, and of the Universidad Nacional de General San Martín. N.I. and R.A.U. are members of the Research Career of CONICET.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Instituto de Investigaciones Biotecnológicas, Universidad Nacional de Gral San Martín, Av. General Paz entre Av. Constituyentes y Albarellos, San Martin 1650, Pcia de Buenos Aires, Argentina. Phone: 54-1-752-0021. Fax: 54-1-752-9639. E-mail: rugalde{at}inti.gov.ar.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altabe, S.,
N. Iñón de Iannino,
D. de Mendoza, and R. A. Ugalde.
1990.
Expression of the Agrobacterium tumefaciens chvB virulence region in Azospirillum spp.
J. Bacteriol.
172:2563-2567 |
| 2. |
Be, A.,
A. Amemura, and S. Higashi.
1982.
Studies on cyclic (1-2) glucan obtained from periplasmic space of Rhizobium trifolii cells.
Plant Soil
64:315-324.
|
| 3. |
Briones, G.,
N. Iñón de Iannino,
M. Steinberg, and R. A. Ugalde.
1997.
Periplasmic cyclic 1,2- -glucan in Brucella spp. is not osmoregulated.
Microbiology
143:1115-1124 |
| 4. |
Castro, O. A.,
A. Zorreguieta,
V. Ielmini,
G. Vega, and L. Ielpi.
1996.
Cyclic -(1-2)-glucan synthesis in Rhizobiaceae: role of the 319-kilodalton protein intermediate.
J. Bacteriol.
178:6043-6048 |
| 5. | Cherwonogrodzky, J. W., G. Dubray, E. Moreno, and H. Mayer. 1990. Antigens of Brucella, p. 19-64. In K. Nielsen, and J. R. Duncan (ed.), Animal brucellosis. CRC Press, Inc., Boca Raton, Fla. |
| 6. | Comerci, D. J., G. D. Pollevick, A. M. Vigliocco, A. C. C. Frasch, and R. A. Ugalde. Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19. Infect. Immun. 66:3862-3866. |
| 7. | De Lay, J., W. Mannheim, P. Segers, A. Lievens, M. Denijn, M. Vanhoucke, and M. Gillis. 1987. Ribosomal ribonucleic acid cistron similarities and taxonomic neighborhood of Brucella and CDC group Vd. Int. J. Syst. Bacteriol. 37:35-42. |
| 8. | Dische, Z. 1962. General color reactions. Methods Carbohydr. Chem. 1:478-492. |
| 9. |
Ditta, G.,
S. Stanfield,
C. Corbin, and D. R. Helinski.
1980.
Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti.
Proc. Natl. Acad. Sci. USA
77:7347-7351 |
| 10. |
Douglas, C. J.,
W. Halperin, and E. W. Nester.
1982.
Agrobacterium tumefaciens mutants affected in attachment to plant cells.
J. Bacteriol.
152:1265-1275 |
| 11. |
Douglas, C. J.,
R. J. Staneloni,
R. A. Rubin, and E. W. Nester.
1985.
Identification and genetic analysis of an Agrobacterium tumefaciens chromosomal virulence region.
J. Bacteriol.
161:850-860 |
| 12. |
Dylan, T.,
L. Ielpi,
S. Stanfield,
L. Kashyap,
C. Douglas,
M. Yanofsky,
E. W. Nester,
D. R. Helinski, and G. Ditta.
1986.
Rhizobium meliloti genes required for nodule development are related to chromosomal virulence genes in Agrobacterium tumefaciens.
Proc. Natl. Acad. Sci. USA
83:4403-4407 |
| 13. |
Garfinkel, D. J., and E. W. Nester.
1980.
Agrobacterium tumefaciens mutants affected in crown gall tumorigenesis and octopine catabolism.
J. Bacteriol.
144:732-743 |
| 14. |
Geremia, R. A.,
S. Cavaignac,
A. Zorreguieta,
N. Toro,
J. Olivares, and R. A. Ugalde.
1987.
A Rhizobium meliloti mutant that forms ineffective pseudonodules in alfalfa produces exopolysaccharide but fails to form (1-2)glucan.
J. Bacteriol.
169:880-884 |
| 15. |
Higgins, D. G., and P. M. Sharp.
1989.
Fast and sensitive multiple sequence alignments on a microcomputer.
CABIOS
5:151-153 |
| 16. | Hirsch, P., and J. Beringer. 1984. A physical map of pPH1JI and pJB4JI. Plasmid 12:139-141[Medline]. |
| 17. | Hisamatsu, M., A. Amemura, K. Koizumi, T. Utamura, and Y. Okada. 1983. Structural studies on cyclic(1-2)-beta-D-glucans (cyclosophoraose) produced by Agrobacterium and Rhizobium. Carbohydr. Res. 121:31-40. |
| 18. |
Hull, R. A.,
R. E. Gill,
O. Hsu,
B. Minshew, and S. Falkow.
1981.
Construction and expression of recombinant plasmids encoding type I or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.
Infect. Immun.
33:933-938 |
| 19. |
Ielpi, L.,
T. Dylan,
G. S. Ditta,
D. R. Helinski, and S. W. Stanfield.
1990.
The ndvB locus of Rhizobium meliloti encodes a 319-kDa protein involved in the production of (1-2)-glucan.
J. Biol. Chem.
265:2843-2851 |
| 20. |
Iñón de Iannino, N.,
G. Briones,
G. Kreiman, and R. A. Ugalde.
1996.
Characterization of the biosynthesis of (1-2) cyclic glucan in R. fredii. (1-2) Glucan has no apparent role in nodule invasion of McCall and Peking soybean cultivars.
Cell. Mol. Biol.
42:617-629.
|
| 21. |
Iñón de Iannino, N., and R. A. Ugalde.
1989.
Biochemical characterization of avirulent Agrobacterium tumefaciens chvA mutants: synthesis and excretion of (1-2)glucan.
J. Bacteriol.
171:2842-2849 |
| 22. |
Iñón de Iannino, N., and R. A. Ugalde.
1993.
Biosynthesis of cyclic (1-3), (1-6) glucan in Bradyrhizobium spp.
Arch. Microbiol.
159:30-38[Medline].
|
| 23. | Knauf, V. C., and E. W. Nester. 1983. Wide host range cloning vectors: a cosmid clone bank of an Agrobacterium Ti plasmid. Plasmid 8:45-54. |
| 24. | Kovach, M. E., P. H. Elzer, D. S. Hill, G. T. Robertson, M. A. Farris, R. M. Roop II, and K. M. Peterson. 1995. Four new derivatives of the broad-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166:175-176[Medline]. |
| 25. |
Long, S.,
G. S. Ditta, and D. R. Helinski.
1982.
Heme biosynthesis in Rhizobium. Identification of a cloned gene coding -aminolevulinic acid synthetase from Rhizobium meliloti.
J. Biol. Chem.
257:8724-8730 |
| 26. |
Miller, K. J.,
E. P. Kennedy, and V. N. Reinhold.
1986.
Osmotic adaptation by Gram-negative bacteria: possible role for periplasmic oligosaccharides.
Science
231:48-51 |
| 27. | Osborn, M., and R. Munson. 1984. Separation of inner (cytoplasmic) and outer membranes of Gram-negative bacteria. Methods Enzymol. 31A:642-653. |
| 28. |
Puvanesarajah, V.,
F. M. Schell,
G. Stacey,
C. J. Douglas, and E. W. Nester.
1985.
Role for 2-linked -D-glucan in the virulence of Agrobacterium tumefaciens.
J. Bacteriol.
164:102-106 |
| 29. | Reichenbecher, M., F. Lottspeich, and K. Bronnenmeier. 1997. Purification and properties of a cellobiose phosphorylase (CepA) and a cellodextrin phosphorylase (CepB) from the cellulolytic thermophile Clostridium stercorarium. Eur. J. Biochem. 247:262-267[Medline]. |
| 30. | Rost, B., P. Fariselli, and R. Casadio. 1996. Topology prediction for helical transmembrane proteins at 86% accuracy. Protein Sci. 5:1704-1718[Medline]. |
| 31. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 32. | Sangari, F. J., J. M. Garcia-Lobo, and J. Agüero. 1994. The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes. FEMS Microbiol. Lett. 121:337-342[Medline]. |
| 33. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 34. | Smith, L. D., and T. A. Ficht. 1990. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17:209-229[Medline]. |
| 35. |
Stachel, S. E.,
G. An,
C. Flores, and E. W. Nester.
1985.
A Tn3 lacZ transposon for the random generation of -galactosidase gene fusions: application to the analysis of gene expression in Agrobacterium.
EMBO J.
4:891-898[Medline].
|
| 36. | Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and D. Brees. 1995. Comparison of the immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus S19 or RB51. Infect. Immun. 63:264-270[Abstract]. |
| 37. | Tolmasky, M. E., A. E. Gammie, and J. H. Crosa. 1992. Characterization of the rec A gene of Vibrio anguillarum. Gene 110:41-48[Medline]. |
| 38. |
Toro, N., and J. Olivares.
1986.
Analysis of Rhizobium meliloti Sym mutants obtained by heat treatment.
Appl. Environ. Microbiol.
51:1148-1150 |
| 39. | Vincent, J. M. 1970. A manual for practical study of root-nodule bacteria, p. 90-121. Blackwell Scientific Publications Ltd., Oxford, England. |
| 40. |
Wacek, T. J., and W. J. Brill.
1976.
Simple rapid assay for screening nitrogen fixing ability in soybean.
Crop Sci.
16:519-522.
|
| 41. | York, W. S., M. McNeil, A. G. Darvill, and P. Albersheim. 1978. Beta-2-linked glucans secreted by fast-growing species of Rhizobium. J. Bacteriol. 142:243-248. |
| 42. |
Zevenhuizen, L. P. T. M., and A. R. W. van Neerven.
1983.
(1-2)- -D-Glucan and acyclic oligosaccharides produced by Rhizobium meliloti.
Carbohydr. Res.
118:127-134.
|
| 43. |
Zevenhuizen, L. P. T. M.,
A. van Veldhuizen, and R. H. Fokkens.
1990.
Re-examination of cellular cyclic 1-2-glucans of Rhizobiaceae: distribution of ring sizes and degrees of glycerol-1-phosphate substitution.
Antonie Leeuwenhoek
57:173-178.
|
| 44. | Zorreguieta, A., R. A. Geremia, S. Cavaignac, G. A. Cangelosi, E. W. Nester, and R. A. Ugalde. 1988. Identification of the product of an Agrobacterium tumefaciens chromosomal virulence gene. Mol. Plant Microbe Interact. 3:121-127. |
| 45. |
Zorreguieta, A., and R. A. Ugalde.
1986.
Formation in Rhizobium and Agrobacterium spp. of a 235-kilodalton protein intermediate in -D(1,2) glucan synthesis.
J. Bacteriol.
167:947-951 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»